Answers are grounded in this paper and cite their sources.
Tapering of tacrolimus was possible in most patients with well-controlled anti-acetylcholine receptor antibody-positive MG. Early age at onset and a large reduction from maintenance dosage were associated with exacerbation. Reductions ≤1.5 mg/day from the maintenance dosage should be considered for patients with late-onset disease.
No takes yet. Share an insight, caveat, or question.
Nishida et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: